MedPath

Sim (Scratch in Miscarriage) Study

Not Applicable
Completed
Conditions
Recurrent Miscarriage
Interventions
Other: Endometrial scratch
Other: Touching the cervix
Registration Number
NCT02681627
Lead Sponsor
University Hospitals Coventry and Warwickshire NHS Trust
Brief Summary

There is increasing amount of evidence which suggests that miscarriage is related to a primary endometrial problem. Recent cochrane meta-analysis (March 2015) has proven that endometrial scratch improves live birth in women who underwent IVF.

The aim of the study is to find out if scratch of the endometrium prevents recurrent miscarriage.

Detailed Description

The Warwick BRU-RH (Biomedical Research Unit- Reproductive Health) hypothesis is that failed pregnancies are the result of failed decidualisation of the endometrium.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
109
Inclusion Criteria
  1. Provision of written informed consent
  2. Actively trying for a pregnancy
Exclusion Criteria
  1. No active treatment in pregnancy
  2. Inherited or acquired thrombophilia
  3. Medical conditions- diabetes,hypertension,thyroid disorders
  4. inability to tolerate internal examinations
  5. uterine anomalies
  6. Previous entry or randomisation in the present trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
endometrial scratchEndometrial scratchPatient will be randomised to the intervention arm which is the luteal phase endometrial scratch
touching cervixTouching the cervixPatient will have a speculum examination and cleaning of the cervix with cotton tip with saline but no scratch
Primary Outcome Measures
NameTimeMethod
Live Birth Rate after 24 weeks of gestationfrom the recruitment of the first patient up to 12 months after the recruitment of last patient. the live birth rate of all the pregnant patients in the study who delivered after 24 weeks will be included in the outcome.
Secondary Outcome Measures
NameTimeMethod
Miscarriage until 23+6 weeks of gestationfrom the recruitment of the first patient and up to 12 months after the recruitment of last patient. the outcomes of all the pregnant patients in the study who delivered up to 23+6 weeks will be included in the outcome.
Acceptability of the interventionPatient questionnaire will be issued at the time of randomisation. the returned forms up to 4 weeks after randomisation will be analysed and reported. this will be helpful for assessing the patients tolerability of the procedure

To guide future trial set up

Pregnancy complicationsfrom the recruitment of the first patient and up to 12 months after the recruitment of last patient. The patients who delivered after 24 weeks with a live birth will be included in the outcome and the described outcomes will be measured

Such as SGA(small for gestational age),PET( Pre-eclamptic toxaemia),Abruption, Placenta Praevia, Placenta accreta and Preterm delivery

Trial Locations

Locations (1)

University Hospitals of Coventry and Warwickshire NHS Trust

🇬🇧

Coventry, West Midlands, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath